MedPath

REHABILITATION INSTITUTE OF CHICAGO

🇺🇸United States
Ownership
-
Established
1954-01-01
Employees
-
Market Cap
-
Website
http://www.ric.org/

Clinical Trials

166

Active:27
Completed:58

Trial Phases

6 Phases

Early Phase 1:4
Phase 1:8
Phase 2:1
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (146 trials with phase data)• Click on a phase to view related trials

Not Applicable
128 (87.7%)
Phase 1
8 (5.5%)
Early Phase 1
4 (2.7%)
Phase 4
4 (2.7%)
Phase 2
1 (0.7%)
Phase 3
1 (0.7%)

Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia

Not Applicable
Not yet recruiting
Conditions
Stroke
First Posted Date
2025-08-08
Last Posted Date
2025-08-08
Lead Sponsor
Shirley Ryan AbilityLab
Target Recruit Count
20
Registration Number
NCT07113457

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

Not Applicable
Recruiting
Conditions
Stroke
Healthy
First Posted Date
2025-07-11
Last Posted Date
2025-07-11
Lead Sponsor
Shirley Ryan AbilityLab
Target Recruit Count
20
Registration Number
NCT07061691
Locations
🇺🇸

Shirley Ryan AbilityLab, Chicago, Illinois, United States

Neuromusculoskeletal Interface for Bionic Arms

Not Applicable
Not yet recruiting
Conditions
Amputation
Amputation, Traumatic
Amputation, Surgical
Upper Limb Amputation Above Elbow (Injury)
First Posted Date
2025-06-24
Last Posted Date
2025-06-24
Lead Sponsor
Shirley Ryan AbilityLab
Target Recruit Count
12
Registration Number
NCT07032753
Locations
🇺🇸

Shirley Ryan Abilitylab, Chicago, Illinois, United States

Pilot Remote Therapeutic Monitoring in Cancer Patients

Not Applicable
Not yet recruiting
Conditions
Cancer
First Posted Date
2025-06-05
Last Posted Date
2025-06-05
Lead Sponsor
Shirley Ryan AbilityLab
Target Recruit Count
25
Registration Number
NCT07007039
Locations
🇺🇸

Shirley Ryan AbilityLab, Chicago, Illinois, United States

Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors

Early Phase 1
Not yet recruiting
Conditions
Healthy
First Posted Date
2025-05-31
Last Posted Date
2025-07-30
Lead Sponsor
Shirley Ryan AbilityLab
Target Recruit Count
20
Registration Number
NCT06999213
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 34
  • Next

News

NervGen Pharma to Present Phase 1b/2a Trial of NVG-291 for Spinal Cord Injury at Upcoming Investor Event

NervGen Pharma will host a virtual investor event on April 9, 2025, featuring key opinion leaders to discuss the unmet medical needs and treatment landscape for spinal cord injury patients.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.